James Smith

James Smith is currently a Senior Manager in Regulatory Affairs at Amgen, having previously held the role of Vice President of Regulatory Affairs at NeoVac. With a solid foundation in pharmaceutical regulatory affairs, they have worked on high-profile projects, including the COVID-19 vaccine, demonstrating a consistent ability to manage complex regulatory strategies across multiple regions. James earned a PhD in Chemistry from Durham University and a Master’s degree in Pharmacy from the University of Nottingham, showcasing a robust academic background complemented by diverse roles in clinical writing, regulatory strategy, and research. Their previous experience includes significant contributions at Pfizer and Bristol-Myers Squibb, where their hard work and expertise in regulatory processes were recognized through multiple awards.